Explore Our Comprehensive Pharmaceuticals Industry Research Reports
U
2024
Immunotherapy drugs are used to enhance or suppress the immune system of the body. They are mostly used in the treatment of cancer and act by stimulating the ...
Report Code : A03238 | Category : Life Sciences
P
2019
The China oncology drugs market was valued at $6,498.2 million in 2018 and is projected to reach $12,688.7 million by 2026, registering a CAGR of 8.7% from 2019 ...
Report Code : A04505 | Pages : 135 | Category : Life Sciences
P
2019
The Japan oncology drugs market size was accounted for $9,405 million in 2018, and is expected to reach $14,109 million by 2026, registering a CAGR of 5.2% from 2019 to 2026.
Report Code : A05277 | Pages : 147 | Category : Life Sciences
U
2024
The oncolytic virus immunotherapy involves the use of viruses to infect and subsequently eliminate cancerous cells. Cancer cells are known to exhibit impaired antiviral defenses, which make them ...
Report Code : A11451 | Category : Life Sciences
P
2024
Research study titled U.S. Neuroblastoma Drugs Market: In offering segment, U.S. sub-segment is expected to expand at a fastest CAGR during the forecast period.
Report Code : A315384 | Pages : 70 | Category : Life Sciences
P
2024
The Canada Neuroblastoma Drugs Market is expected to expand at a promising compound annual growth rate (CAGR) between 2023 to 2032. The Canada Neuroblastoma Drugs Market growth is attributed to various driving factors and revenue opportunities.
Report Code : A315385 | Pages : 83 | Category : Life Sciences
P
2024
Mexico Neuroblastoma Drugs Market size is projected to increase at a lucrative rate during the forecast period. The Mexico Neuroblastoma Drugs Market report covers the drivers, restraints, and opportunities of the market. It focuses on the current market strategies adopted by the key players in the industry.
Report Code : A315386 | Pages : 90 | Category : Life Sciences
P
2024
The current Europe Neuroblastoma Drugs Market is quantitatively analyzed from 2022 to 2032 to benchmark the financial competency.
Report Code : A315387 | Pages : 105 | Category : Life Sciences
P
2024
The Germany Neuroblastoma Drugs Market achieved significant revenue share in base year of analysis. The Germany Neuroblastoma Drugs Market size is expected to account for a considerable growth rate between 2023 to 2032.
Report Code : A315388 | Pages : 82 | Category : Life Sciences
P
2024
Research study titled France Neuroblastoma Drugs Market: In offering segment, U.S. sub-segment is expected to expand at a fastest CAGR during the forecast period.
Report Code : A315389 | Pages : 79 | Category : Life Sciences
Register and Earn 500 Loyalty Points
An Email Verification Code has been sent to your email address!
Please check your inbox and, if you don't find it there, also look in your junk folder.